Private Equity

Updated:

Taikang Investment

Taikang Investment is a private equity based in Beijing; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts...

Taikang Investment logo

Taikang Investment

Taikang Investment is a private equity firm based in Beijing, China. It focuses on venture capital investments.

General information

Firm type

Private Equity

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Principals

Chen Dongsheng

Founder and Chairman, Taikang Insurance Group

Liu Tingjun

Chairman, Taikang Investment

Duan Guosheng

CEO, Taikang Investment

Sector focus

Enterprise SoftwareAI/MLDigital HealthFinTechIndustrial TechEnergy Transition & Renewables

Frequently asked questions

Who makes investment decisions at Taikang Investment?

CEO Duan Guosheng leads the investment team and reports to Chairman Liu Tingjun. The broader Taikang Insurance Group — founded and chaired by Chen Dongsheng — sets the strategic allocation framework within which the platform operates. Specific deal approvals follow an internal investment committee process reflecting both the PE team's analysis and the parent's balance-sheet priorities.

How is Taikang Investment structurally tied to Taikang Insurance Group?

Taikang Investment is a wholly owned asset-management subsidiary of Taikang Insurance Group, one of China's largest non-state insurers. It functions as the group's principal private-equity and venture arm, deploying a portion of the group's general-account assets into alternative investments. The parent's liability structure — long-duration life and health policies — directly shapes the subsidiary's ability to hold illiquid positions across prolonged investment horizons.

Does Taikang Investment focus exclusively on healthcare and insurance-adjacent sectors?

Healthcare and digital health are core concentrations — the firm has backed companies like WeDoctor — but Taikang Investment also pursues enterprise software, AI/ML, industrial automation, and clean-energy technology. The common thread is long-duration capital deployment in sectors where regulatory and technical maturation cycles play out over years, rather than quarters.

How does the firm source deal flow?

Sourcing relies heavily on Taikang Insurance Group's domestic corporate relationships, healthcare-provider partnerships, and co-investor networks with other Chinese institutional investors — including China Life, CICC, and CITIC Capital. The group's position as a large buyer of health benefits and retirement services also generates proprietary insight into which startups are gaining traction inside China's provider ecosystem.

What investment stages does Taikang Investment typically target?

The platform invests across early-stage, expansion, and late-stage venture, as well as select growth-equity and pre-IPO rounds. This wide stage coverage reflects an insurance-balance-sheet mandate rather than a fund-vehicle mandate — so the team can enter early in a company's life and hold through public listing without needing to recycle capital on a fixed schedule.

Does Taikang Investment co-invest alongside external GPs?

Yes. The firm participates in direct equity rounds and structured co-investments with other domestic and international institutional investors. It also makes fund commitments to select venture and growth funds, particularly those providing exposure to US and Southeast Asian technology companies outside its direct-investment geographic core.

How does Taikang Investment interact with the parent's healthcare operations?

Taikang Group runs a nationwide network of retirement communities and healthcare facilities under Taikang Community and Taikang Healthcare. Taikang Investment's MedTech and digital-health portfolio companies can pilot products inside that captive ecosystem, giving them a commercial proving ground that independent venture-backed startups typically lack.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles